AVH vs NAN

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

AVH

AVITA MED CDI 5:1 [AVH]

50MEDIUM

NAN

NANOSONICS FPO [NAN]

52MEDIUM

Score Breakdown

AVH NAN
Technical
44
49
Catalyst
53
53
Sentiment
50
50
Fundamental
58
94
Momentum
45
41
Risk Gate
46
40

Key Metrics

AVH Metric NAN
$173.9MMarket Cap$965.5M
426KAvg Volume (20d)440K
+0.3%Short Interest+6.9%
$1.98052-Week High$4.770
$1.00052-Week Low$2.960
-1.3%Daily Change-0.3%
$1.135Reference Price$3.220
N/AROE+10.1%
-62.7%Profit Margin+9.9%

Active Signals

AVH Signals

●RSI drifting toward oversold territory — worth watching
●MACD crossed bearish — momentum is fading
●Smart money may be accumulating — volume is flowing in even though price hasn't moved yet
●Took a hit — down 18.9% over the last 5 days
●Beating the Small Ords index — relative strength of 1.12, so it's outpacing the pack
●Below the 200-day average — the long-term trend is still working against it
●Critical cash runway (1.8 quarters)
●Low P/S ratio (2.4x)

NAN Signals

●MACD momentum is losing steam
●Stochastic is deep in oversold territory — bounce conditions forming
●Below the 200-day average — the long-term trend is still working against it
●Cash positive / operating cashflow positive
●Low P/S ratio (4.7x)
●Moderate revenue growth (+9%)
●Piotroski F-Score strong (8/9, low-confidence approx)
●EPS estimates revised upward (+3pts)

Ask Scout AI to compare AVH and NAN in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

AVH vs ONE →AVH vs PEB →AVH vs PHX →AVH vs PKY →AVH vs SLD →
AVH Full Analysis → NAN Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).